Skip to main content
Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.35
-0.18 (-3.25%)
At close: Mar 9, 2026, 4:00 PM EDT
5.36
+0.01 (0.24%)
After-hours: Mar 9, 2026, 4:49 PM EDT

Evolus Revenue

In the year 2025, Evolus had annual revenue of $297.18M with 11.61% growth. Evolus had revenue of $90.30M in the quarter ending December 31, 2025, with 14.38% growth.

Revenue (ttm)
$297.18M
Revenue Growth
+11.61%
P/S Ratio
1.17
Revenue / Employee
$889,749
Employees
334
Market Cap
348.07M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025297.18M30.90M11.61%
Dec 31, 2024266.27M64.19M31.76%
Dec 31, 2023202.09M53.47M35.98%
Dec 31, 2022148.62M48.94M49.10%
Dec 31, 202199.67M43.13M76.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 742.90M
Organogenesis Holdings 564.17M
Ironwood Pharmaceuticals 296.15M
Akebia Therapeutics 236.20M
Canopy Growth 203.04M
Kamada 174.79M
SIGA Technologies 172.25M
Lifecore Biomedical 128.87M
Revenue Rankings

EOLS News

More News